CN104740335A - Dendrobium officinale leaf extract with uric acid reducing function and application of dendrobium officinale leaf extract - Google Patents

Dendrobium officinale leaf extract with uric acid reducing function and application of dendrobium officinale leaf extract Download PDF

Info

Publication number
CN104740335A
CN104740335A CN201310753697.5A CN201310753697A CN104740335A CN 104740335 A CN104740335 A CN 104740335A CN 201310753697 A CN201310753697 A CN 201310753697A CN 104740335 A CN104740335 A CN 104740335A
Authority
CN
China
Prior art keywords
leaf extract
dendrobium officinale
herba dendrobii
officinale leaf
uric acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201310753697.5A
Other languages
Chinese (zh)
Inventor
吕圭源
陈素红
胡秀
雷珊珊
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wenzhou Medical University
Zhejiang Chinese Medicine University ZCMU
Original Assignee
Wenzhou Medical University
Zhejiang Chinese Medicine University ZCMU
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wenzhou Medical University, Zhejiang Chinese Medicine University ZCMU filed Critical Wenzhou Medical University
Priority to CN201310753697.5A priority Critical patent/CN104740335A/en
Publication of CN104740335A publication Critical patent/CN104740335A/en
Pending legal-status Critical Current

Links

Abstract

The invention discloses a dendrobium officinale leaf extract with a uric acid reducing function and application of the dendrobium officinale leaf extract. The dendrobium officinale leaf extract is prepared through the following steps: cleaning and drying the dendrobium officinale leaves; mechanically pulverizing; carrying out reflux extraction by a 0-30V% ethanol solution for 1-3 times, wherein the time of each reflux extraction is 1-3h and the dosage of each reflux extraction is 5-20 times of the medicine weight; combining the filtrates; recovering the ethanol; and carrying out vacuum concentration to obtain the dendrobium officinale leaf extract. The dendrobium officinale leaf extract can be used for preventing medicines or food for preventing and treating hyperuricemia; the dendrobium officinale leaf extract relies on the dendrobium officinale leaves to develop the effects of the dendrobium officinale leaves, so that the new medicinal resources of the dendrobium officinale are expanded and the resource waste is decreased at the same time.

Description

A kind of Herba Dendrobii leaf extract and purposes with uric acid resisting effect
Technical field
The invention belongs to medical art, particularly relate to a kind of Herba Dendrobii leaf extract and the purposes with uric acid resisting effect.
Background technology
The sickness rate showed increased in recent years of gout and hyperuricemia, the sickness rate of hyperuricemia reaches 10%, and the pathogenesis basis of gout is hyperuricemia, is because dietary structure is uneven, causes many kinds of substance metabolism disorder in human body and the disease that causes.Just damage kidney and other organs, the renal calculus of clinical findings unknown cause, the patient of renal failure before a large amount of Patients with Hyperuricemia generation gouts, one of its cause of disease is exactly caused by long-term blood uric acid (UA) increases.So find that the patient that UA obviously raises must do uric acid resisting process.In recent years much research shows, hyperuricemia is relevant to the generation of hypertension, impaired glucose tolerance, central obesity, disorders of lipid metabolism, atherosclerosis etc.Along with socioeconomic development and growth in the living standard, the improvement of people's nutritional condition, take in animal proteinum, the increase of fat and the change (drink, smoking etc.) of life-form structure, obese people increases, and the patient of hyperuricemia also increases year by year.Hyperuricemia is divided into generation to increase type and excretion reduction type according to the origin cause of formation by modern medicine, and selects suppression uricopoiesis medicine as allopurinol according to renal function situation, or promotes that urate excretion medicine is as benzbromarone, probenecid, sulphinpyrazone.Although these medicines have obvious uric acid resisting effect, side effect is also comparatively large, as erythra, heating, hepatic renal dysfunction, hemopoietic function exception, gout outbreak etc., thus limits the scope of its application.Therefore, developmental research drug effect is clear and definite and the novel anti-antihyperuricemic disease drug of safety is very necessary.The maximum characteristics and advantages of Chinese medicine is organic conception, and it, by Mutiple Targets, multipath, makes uric acid steadily decline, produce certain Renoprotective Effect.Therefore treatment by Chinese herbs metabolic arthritis is to improving the quality of life of patient and improving prognosis and have very large advantage.
The dry stem of Herba Dendrobii Dendrobium officinale Kimura et Migo, sweet in the mouth, is slightly cold.Return stomach, kidney channel, there is reinforcing stomach reg fluid, nourishing YIN and clearing away heat.
Herba Dendrobii leaf, does not belong to medicinal part at present, can not use as bread and cheese; But output is very large, and research shows, Herba Dendrobii leaf and Herba Dendrobii medical material (stem), containing multiple types chemical composition together, also have the function that part is similar, but the huge Herba Dendrobii leaf of current production rate can only do refuse process.There is no the medicinal part Herba Dendrobii leaf recorded during the present invention selects " Chinese Pharmacopoeia " as support, develop its effect, expand the medicine resource that Herba Dendrobii is new, decrease the waste of resource simultaneously.Inventor is found by research, and Herba Dendrobii leaf extract can reduce rat model serum uric acid level, can be used for preventing and treating medicine and health food that hyperuricemia is major function.
Summary of the invention
The object of the invention is to for the deficiencies in the prior art, a kind of Herba Dendrobii leaf extract and the purposes with uric acid resisting effect are provided.
The present invention solves the problems of the technologies described above adopted technical scheme: a kind of Herba Dendrobii leaf extract with uric acid resisting effect, described Herba Dendrobii leaf extract prepares by the following method: Herba Dendrobii leaf is cleaned, after drying, mechanical activation comminution, alcohol reflux with 0 ~ 30% 1 ~ 3 time, each 1 ~ 3h, each consumption is respectively 5 ~ 20 times of medical material weight, merging filtrate, and concentrating under reduced pressure obtains Herba Dendrobii leaf extract.
This Herba Dendrobii leaf extract can be used for preparing the hypertensive medicine of prevention and therapy or food.This Herba Dendrobii leaf extract can with the adjuvant approved on medicament or food, adopt Modern preparations technology, make based on the extractum of Herba Dendrobii leaf extract, the various dosage forms such as tablet, granule, pill, capsule, powder, oral liquid.
The invention has the beneficial effects as follows there is no the medicinal part Herba Dendrobii leaf recorded during the present invention selects " Chinese Pharmacopoeia " as support, develop its effect, expand the medicine resource that Herba Dendrobii is new, decrease the waste of resource simultaneously.The experiment of inventor shows: this Herba Dendrobii leaf extract significantly can reduce the serum uric acid level of rat model, can be used for preventing and treating medicine and health food that hyperuricemia is major function.
Detailed description of the invention
Further describe the present invention according to embodiment below, effect of the present invention will be reflected more clearly.
Embodiment 1
Herba Dendrobii leaf is cleaned, after drying, mechanical activation comminution, adding 5 times amount concentration of volume percent is the alcoholic solution of 30%, and extract 3 times, each 1h, merging filtrate, concentrating under reduced pressure obtains Herba Dendrobii leaf extract, and 4 DEG C of refrigerator cold-storages are for subsequent use.
Embodiment 2
Herba Dendrobii leaf is cleaned, after drying, mechanical activation comminution, adds 15 times of water gagings, and extract 2 times, each 2 hours, merging filtrate, concentrating under reduced pressure obtains Herba Dendrobii leaf extract, and 4 DEG C of refrigerator cold-storages are for subsequent use.
Embodiment 3
Herba Dendrobii leaf is cleaned, after drying, mechanical activation comminution, adds 20 times amount 15% alcoholic solution, extracts 3 hours, and filtration, filtrate reduced in volume obtains Herba Dendrobii leaf extract, and 4 DEG C of refrigerator cold-storages are for subsequent use.
Embodiment 4
The serum uric acid level of the Hypertensive Rats that Herba Dendrobii dried leaves water extract is drunk to chronic stress combination through long term administration discovery, prepared by high glucose and high fat has significant reducing effect.
1 experiment material and instrument
1.1 materials and instrument
1.1 animal SD rats, male and female half and half, body weight (200 ~ 550g), 40.The quality certification number: scxk (Shanghai) 20080033.
1.2 Pharmaceutical formulations
1.2.1 by reagent
Herba Dendrobii leaf water extract high dose 5g/kg, middle dosage 2.5g/kg, low dosage 1.25g/kg.4 DEG C of refrigerator cold-storages are for subsequent use.
1.2.2 positive drug Captopril tablets, specification 12.5mg/ sheet, lot number 120618, Henan Zhong Jie pharmaceutcal corporation, Ltd, being mixed with concentration with distilled water is 0.015g/kg.
1.3 electronics balance CP114 (Shanghai Ao Haosi Instrument Ltd.); YP15KN-electronic weighing balance (Shanghai Hengping Science Instrument Co., Ltd.); YF-40 traditional Chinese medicine extracting machine (the former medical treatment in East China, Beijing); The multiplex vacuum pump of SHB-B95A type circulating water type (Shanghai Yu Kang Science & Teaching Instrument equipment company limited); GG-17 Rotary Evaporators (Shanghai Yu Kang Science & Teaching Instrument equipment company limited); Lifting thermostat water bath (Hangzhou David's Science & Teaching Instrument company) DLSB-30/30 DEG C sub-cooled circulating pump (Hangzhou Hui Chuan instrument and equipment company limited); CM-230 pure water instrument (Hangzhou Yongjieda Cleaning Technology Co., Ltd); KQ-500DE type numerical control ultrasonic cleaner (Kunshan Ultrasonic Instruments Co., Ltd.); 501-thermostatted water oil bath pan, SHB-III circulating water type vacuum pump, DLSB--5/10 DEG C sub-cooled circulating pump (Hangzhou Hui Chuan instrument and equipment company limited); TBA-A0FR (ACCUTE) automatic clinical chemistry analyzer (wide medical Co., Ltd. of Japanese Toshiba three).
2 experimental techniques
60 rat models are divided into normal group according to body weight by 2.1 administration leaves at random, model control group, dosage (2.5g/kg), Herba Dendrobii dried leaves low dosage (1.25g/kg) in Herba Dendrobii dried leaves high dose (5g/kg) group, Herba Dendrobii dried leaves, normal group gives purified water, normal diet, model group and administration group administration Chinese liquor, high glucose and high fat feedstuff.Gastric infusion, model group and normal group gavage give tap water, and administration group gives corresponding medicine, and administration capacity is 1ml/100g body weight.
2.2 observation index successive administrations 14 weeks, get hematometry rat blood serum uric acid (UA) level in every 2 weeks.
2.3 statistics with analyze measure data result with represent, group difference adopts t-test.
3 experimental results
Normal group, model group and each administration group blood pressure situation during 3.1 administrations
Be combined than chronic stress the uric acid preparing hypertension model with high glucose and high fat of drinking with normal group obviously to raise (P<0.01); With model group ratio, administration 4 weeks Herba Dendrobii dried leaves water extract high doses significantly can reduce rat model UA level (P<0.01), and uric acid resisting effect steadily continues.The results are shown in Table 1.
The change of table 1 successive administration rat UA level ( n=10)
Note: with normal group ratio, * P<0.05, * * P<0.01; Compare with model control group, p<0.05, △ △p<0.01.

Claims (2)

1. one kind has the Herba Dendrobii leaf extract of uric acid resisting effect, it is characterized in that, described Herba Dendrobii leaf extract prepares by the following method: Herba Dendrobii leaf is cleaned, after drying, mechanical activation comminution is the alcoholic solution reflux, extract, 1 ~ 3 time of 0 ~ 30% with concentration of volume percent, each 1 ~ 3h, each consumption is respectively 5 ~ 20 times of medical material weight, merging filtrate, reclaim ethanol, concentrating under reduced pressure obtains Herba Dendrobii leaf extract.
2. the purposes of Herba Dendrobii leaf extract in the medicine preparing prevention and therapy hyperuricemia or food described in a claim 1.
CN201310753697.5A 2013-12-30 2013-12-30 Dendrobium officinale leaf extract with uric acid reducing function and application of dendrobium officinale leaf extract Pending CN104740335A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201310753697.5A CN104740335A (en) 2013-12-30 2013-12-30 Dendrobium officinale leaf extract with uric acid reducing function and application of dendrobium officinale leaf extract

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201310753697.5A CN104740335A (en) 2013-12-30 2013-12-30 Dendrobium officinale leaf extract with uric acid reducing function and application of dendrobium officinale leaf extract

Publications (1)

Publication Number Publication Date
CN104740335A true CN104740335A (en) 2015-07-01

Family

ID=53580955

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201310753697.5A Pending CN104740335A (en) 2013-12-30 2013-12-30 Dendrobium officinale leaf extract with uric acid reducing function and application of dendrobium officinale leaf extract

Country Status (1)

Country Link
CN (1) CN104740335A (en)

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105685186A (en) * 2016-03-31 2016-06-22 浙江科技学院 Dendrobium officinale leaf biscuit and production method thereof
CN106039027A (en) * 2016-06-23 2016-10-26 云南润紫源生物科技股份有限公司 Dendrobium candidum leaf lozenge as well as preparation method and application thereof
CN106377672A (en) * 2015-10-14 2017-02-08 重庆蹇家坪农业科技发展有限公司 Preparation method for extract of Folium Dendrobium officinale
CN108310227A (en) * 2018-04-01 2018-07-24 张奉明 A kind of dendrobium candidum composition and preparation method thereof of beneficial bony articulation health
CN109663062A (en) * 2018-09-16 2019-04-23 瓦房店市祖御康生物富硒产品销售处 A kind of selenium-rich peptide dendrobium nutrient alkali and its boiling method, application
CN112057559A (en) * 2020-10-10 2020-12-11 中国药科大学 Application of dendrobium huoshanense extract in medicine for preventing, relieving and/or treating uric acid renal disease
CN115399444A (en) * 2022-09-28 2022-11-29 清华大学无锡应用技术研究院 Method for making bean product suitable for people with high uric acid

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102743421A (en) * 2012-07-12 2012-10-24 万福群 Synsepalum dulcificum Denill tree branch and leaf extract and extraction method and application of extract
KR20120122407A (en) * 2011-04-29 2012-11-07 주식회사한국전통의학연구소 Composition for Treatment of Renal Cell Carcinoma and Beauty Expenses Composition Comprising Extract of Dendrobii Herba

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20120122407A (en) * 2011-04-29 2012-11-07 주식회사한국전통의학연구소 Composition for Treatment of Renal Cell Carcinoma and Beauty Expenses Composition Comprising Extract of Dendrobii Herba
CN102743421A (en) * 2012-07-12 2012-10-24 万福群 Synsepalum dulcificum Denill tree branch and leaf extract and extraction method and application of extract

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
吕圭源等: "铁皮石斛功效相关药理作用研究进展", 《中国中药杂志》 *
陈立钻等: "《石斛祛病健身妙用》", 31 May 2003, 农村读物出版社 *

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106377672A (en) * 2015-10-14 2017-02-08 重庆蹇家坪农业科技发展有限公司 Preparation method for extract of Folium Dendrobium officinale
CN105685186A (en) * 2016-03-31 2016-06-22 浙江科技学院 Dendrobium officinale leaf biscuit and production method thereof
CN106039027A (en) * 2016-06-23 2016-10-26 云南润紫源生物科技股份有限公司 Dendrobium candidum leaf lozenge as well as preparation method and application thereof
CN108310227A (en) * 2018-04-01 2018-07-24 张奉明 A kind of dendrobium candidum composition and preparation method thereof of beneficial bony articulation health
CN109663062A (en) * 2018-09-16 2019-04-23 瓦房店市祖御康生物富硒产品销售处 A kind of selenium-rich peptide dendrobium nutrient alkali and its boiling method, application
CN112057559A (en) * 2020-10-10 2020-12-11 中国药科大学 Application of dendrobium huoshanense extract in medicine for preventing, relieving and/or treating uric acid renal disease
CN115399444A (en) * 2022-09-28 2022-11-29 清华大学无锡应用技术研究院 Method for making bean product suitable for people with high uric acid

Similar Documents

Publication Publication Date Title
CN104740335A (en) Dendrobium officinale leaf extract with uric acid reducing function and application of dendrobium officinale leaf extract
CN105395919B (en) It is a kind of to contain black fungus extract, the composition with effect for reducing blood fat and preparation method thereof
CN104740336A (en) Dendrobium officinale leaf extract with blood pressure reducing effect and application of dendrobium officinale leaf extract
CN103690795A (en) Dendrobium officinale root extract with blood pressure reduction effect and application of dendrobium officinale root extract
CN104922176A (en) Application of flos chrysanthemi indici extract
CN102551046B (en) Natural health composition for weight reduction and application of same
CN110559403B (en) Traditional Chinese medicine composition for preventing and treating hyperuricemia and preparation method and application thereof
CN105770462A (en) Healthcare tea with blood lipid reducing function
WO2013155995A1 (en) Red yeast and kudzu root pharmaceutical composition for regulating blood lipids and preparation method therefor
CN103610051A (en) Food, healthcare food or medicine composition with lipid-lowering effect as well as preparation methods and applications thereof
CN103229882A (en) Hypertension preventing food health-care tea electuary
CN106562165A (en) Slimming type blended fruit-vegetable juice drink and preparation method thereof
CN103920135B (en) A kind of Thallus Laminariae (Thallus Eckloniae) amino composite sheet reducing uric acid content and preparation method thereof
CN105106300A (en) Use of cyclocarya paliurus extract in preparation of drug for preventing and treating non-alcoholic fatty liver disease
CN108936632A (en) A kind of krill fat capsule and preparation method thereof
CN103461600A (en) Diet health-care weight-reducing tea granule
KR101511364B1 (en) Herbal Extract Composition for Prevention or Treatment of Obesity and Metabolic Syndrome Using Herbal Extract
CN103720808B (en) A kind of composition and use thereof, preparation method with relieving constipation effect
CN104435072B (en) A kind of extract and preparation method thereof with auxiliary hyperglycemic, reducing blood lipid
CN103211055B (en) Pabular health tea electuary for nourishing brain
US20090274781A1 (en) Anti-obesity agent
CN103705768B (en) The compositions of prevention alcoholic liver disease and application thereof
TWI676473B (en) Uses of poria cocos epidermis extract, poricoic acid a, and poricoic acid b in regulating blood glucose level
CN105434886A (en) Dendrobium officinale root extractive with blood-sugar reducing effect and uses thereof
CN105193993B (en) A kind of Chinese medicine composition with blood fat reducing function and preparation method thereof and purposes

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20150701

WD01 Invention patent application deemed withdrawn after publication